CDGEN1.16

General

Cell Line

hPSCreg name ICANi001-A
Cite as:
ICANi001-A (RRID:CVCL_A5RE)
Alternative name(s)
CDGEN1.16
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
ICANi001-A-1
(CDGEN1.16.40.5)
Donor diseases:
hypertrophic cardiomyopathy
UKEi070-A-1
(Rep 28, Iso Co)
Donor diseases:
hypertrophic cardiomyopathy
UKEi070-A-2
(Bi-allelic mutant, Mut 103)
Donor diseases:
hypertrophic cardiomyopathy
TAUi001-A
(UTA.09703.HCMJp)
Donor's gene variants:
JPH2
Donor diseases:
hypertrophic cardiomyopathy
UKKi031-A
(NP0138-8B)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi031-B
(NP0138-19E)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi031-C
(NP0138-31B)
Donor's gene variants:
TNNT2
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi929-A
(CW30245)
Donor diseases:
Hypertrophic Cardiomyopathy
WTSIi461-B
(HPSI0316i-eoko_3)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi514-B
(HPSI0416i-iooi_6)
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi965-A
(CW30288)
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi025-A
(NP0135-1)
Donor's gene variants:
MYH7
Donor diseases:
Rare hypertrophic cardiomyopathy
IBBISTi006-A
(F93 clone 5)
Donor's gene variants:
MYBPC3
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi017-B
(NP0075-10K)
Donor diseases:
Rare hypertrophic cardiomyopathy
IBBISTi006-B
(F93 clone 6)
Donor's gene variants:
MYBPC3
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi017-C
(NP0075-11B)
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi726-A
(CW30001)
Donor diseases:
Hypertrophic Cardiomyopathy
UKKi025-B
(NP0135-2)
Donor's gene variants:
MYH7
Donor diseases:
Rare hypertrophic cardiomyopathy
UKKi025-C
(NP0135-7)
Donor's gene variants:
MYH7
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi731-A
(CW30006)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi736-A
(CW30011)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi741-A
(CW30017)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi742-A
(CW30018)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi744-A
(CW30020)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi752-A
(CW30032)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi00O-A
(CW30346)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi770-A
(CW30054)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi771-A
(CW30055)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi01B-A
(CW30362)
Donor diseases:
Hypertrophic Cardiomyopathy
SCVIi074-A
(SCVIi599C1)
Donor's gene variants:
BAG cochaperone 3
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi779-A
(CW30064)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi781-A
(CW30067)
Donor diseases:
Hypertrophic Cardiomyopathy
WTSIi461-A
(HPSI0316i-eoko_5)
Donor diseases:
Rare hypertrophic cardiomyopathy
WTSIi462-A
(HPSI0316i-miov_1)
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi793-A
(CW30080)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi797-A
(CW30084)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi823-A
(CW30115)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi835-A
(CW30133)
Donor diseases:
Hypertrophic Cardiomyopathy
WTSIi514-A
(HPSI0416i-iooi_1)
Donor diseases:
Rare hypertrophic cardiomyopathy
CIRMi838-A
(CW30139)
Donor diseases:
Hypertrophic Cardiomyopathy
ICGi029-A
(HCM14fm6.2)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi850-A
(CW30155)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi04F-A
(CW30467)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi865-A
(CW30172)
Donor diseases:
Hypertrophic Cardiomyopathy
CIRMi869-A
(CW30177)
Donor diseases:
Hypertrophic Cardiomyopathy
Last update 14th April 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
Owner INSERM U1166-Institute of Cardiometabolism And Nutrition (ICAN)
Distributors
Derivation country France

External Databases

BioSamples SAMEA10202562
Cellosaurus CVCL_A5RE
Wikidata Q107115415

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: allowed
Commercial use: not allowed
Subclones

Donor Information

General Donor Information

Sex female
Age of donor (at collection) 50-54
Ethnicity Caucasian

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Stage
NYHA 4
Synonyms
  • Asymmetric Septal Hypertrophies
  • Hypertrophic Obstructive Cardiomyopathies
  • Cardiomyopathy, hypertrophic
  • Subvalvular Stenosis, Idiopathic Hypertrophic
  • Hypertrophic Obstructive Cardiomyopathy
  • HYPERTR OBSTR CARDIOMYOP
  • hyper. obst. cardiomyopathy
  • SUBVALV STENOSIS
  • HCM - Hypertrophic cardiomyopathy
  • IDIOPATHIC HYPERTROPHIC SUBVALV STENOSIS
  • Obstructive Cardiomyopathy, Hypertrophic
  • Hypertrophies, Asymmetric Septal
  • Hypertrophic Cardiomyopathies
  • Cardiomyopathies, Hypertrophic Obstructive
  • Hypertrophic cardiomyopathy (disorder)
  • HOCM - Hypertrophic obstructive cardiomyopathy
  • Primary hypertrophic cardiomyopathy
  • Idiopathic Hypertrophic Subvalvular Stenosis
  • IHSS
  • primary hypertrophic cardiomyopathy (disorder) [Ambiguous]
  • Idiopathic Hypertrophic Subaortic Stenosis
  • Obstructive cardiomyopathy
  • SUBVALV STENOSIS IDIOPATHIC HYPERTROPHIC
  • Hypertrophy, Asymmetric Septal
  • Hypertrophic obstructive cardiomyopathy (disorder)
  • Septal Hypertrophy, Asymmetric
  • Cardiomyopathies, Hypertrophic
  • IHSSs
  • hypertrophic myocardiopathy
  • Cardiomyopathy, Hypertrophic Obstructive
  • HCM
  • Obstructive Cardiomyopathies, Hypertrophic
  • Asymmetric Septal Hypertrophy
  • Septal Hypertrophies, Asymmetric
  • hypertrophic subaortic stenosis
  • obstructive hypertrophic cardiomyopathy
  • hypertrophic obstructive cardiomyopathy
  • hypertrophic cardiomyopathy
  • familial hypertrophic cardiomyopathy
  • HCM - hypertrophic cardiomyopathy
show more synonyms
Genetic variants
14q11.2
NM_000257.4:c.1208G>T
NP_000248.2:p.Arg403Leu
Heterozygous
VCV000014101.6

Karyotyping (Donor)

Has the donor karyotype been analysed?
Unknown

External Databases (Donor)

BioSamples SAMEA12775561

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Provide contact information of the holder of the original Donor Information Sheet: v.fontaine@ican-institute.org
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Confirm that consent was obtained by a qualified professional Yes
Has the donor agreed to be re-contacted? Unknown
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? No information
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? ANSM
Approval number 151277B-62
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
Age of donor (at collection) 50-54
Passage number reprogrammed 4

Reprogramming method

Vector type Non-integrating
Vector Episomal
Genes
Is reprogramming vector detectable?
No
Methods used
PCR

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Mechanically
CO2 Concentration 5 %
Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
POU5F1 (OCT-4)
Yes
SOX2
Yes
Alkaline Phosphatase
Yes
Self-renewal
Negative
Endoderm
Positive
Mesoderm
Positive
Ectoderm score
Positive
Differentiation Potency
Cardiac Muscle Cell
Ont Id: CL_0000746
In vitro directed differentiation

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
Karyotype_CDGEN1.16
Passage number: 20
Karyotyping method: G-Banding

Other Genotyping (Cell Line)